S-1/AS-1/A
Sep 18, 2026Amended0001193125-26-395559
All companies
Trade Maplight Therapeutics Inc
MA
Maplight Therapeutics Inc
MPLTPublic
PublicUnited States(Nasdaq)Best valuation $707.33M1 market
Public listing
Listed· Nasdaq· Listing market: United StatesListing date
Not available
Offer price
Not available
Shares offered
Not available
Offering proceeds
Not available
Sources: sec-edgar, sec-harvest, nasdaq
IPO Calendar · NasdaqIPO
MPLTPrice
$10.92
24h
-3.53%
Valuation
$707.33M
24h volume
$20.02M
Type
IPO
Trade Maplight Therapeutics IncNow trading publicly. Buy via a broker — opens in a new tab.
IPO Calendar · updated 1h ago
Financials
UnprofitableFrom SEC filings, latest FY ending Dec 31, 2025 · CIK 0001770069.
Revenue
—
Net income
-$161.15M
Gross margin
—
Cash
$46.73M
| Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating income | -$169.08M | -$82.95M | — |
| Net income | -$161.15M | -$77.58M | — |
| R&D expense | $138.35M | $68.52M | — |
| Cash & equivalents | $46.73M | $38.25M | — |
| Total assets | $479.51M | $136.92M | — |
| Total liabilities | $21.14M | $21.72M | — |
| Shareholders' equity | $458.37M | -$193.63M | -$117.59M |
SEC IPO filings
AmendedEDGAR filings resolved from MPLT / CIK 0001770069.
S-1S-1
Sep 9, 2026Filed0001193125-26-386648
424B3424B3
Oct 27, 2025Final prospectus0001193125-25-251611
FWPFWP
Oct 27, 2025Free writing prospectus0001193125-25-250609
Oct 24, 2025Exchange registration0001354457-25-001060
8-A12B8-A12B
Oct 24, 2025Exchange registration0001193125-25-249941
FWPFWP
Oct 6, 2025Free writing prospectus0001193125-25-232052
S-1/AS-1/A
Oct 6, 2025Amended0001193125-25-231829
S-1S-1
Sep 19, 2025Filed0001193125-25-209084
DRSLTRfilename1.htm
Aug 22, 2025Confidential draft0000950123-25-008549
DRS/Afilename1.htm
Aug 22, 2025Confidential draft0000950123-25-008548
UPLOADfilename1.pdf
Aug 12, 2025SEC correspondence0000000000-25-008433
Maplight Therapeutics Inc IPO — frequently asked questions
- When did Maplight Therapeutics Inc go public?
- Maplight Therapeutics Inc has already gone public and now trades publicly on Nasdaq under the ticker MPLT.
- Can I buy Maplight Therapeutics Inc stock?
- Yes — Maplight Therapeutics Inc is publicly traded on Nasdaq as MPLT. You can follow its live price, valuation and post-IPO performance above.
- What is Maplight Therapeutics Inc's valuation?
- Maplight Therapeutics Inc's most recent valuation tracked here is $707.33M, derived from live market prices.